ARTICLE
25 April 2014

FDA Issues Draft Guidance On Honey

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
The FDA released draft guidance for industry on proper labeling of honey and honey products.
United States Food, Drugs, Healthcare, Life Sciences

On April 9, FDA released draft guidance for industry on proper labeling of honey and honey products. The guidance was issued in response to a 2006 petition by the American Beekeeping Federation and other honey-related associations requesting that FDA adopt a U.S. standard of identity for honey. FDA denied the petition in October 2011, concluding that the petitioners' goals could be met by existing authorities, and a standard of identity for honey would not promote honesty and fair dealing in the interest of consumers. More than two years later, the agency issued this guidance "[t]o address the labeling issues relevant to the petition and to reinforce existing laws and regulations to the industry." The guidance defines honey, summarizes FDA's authority over honey and honey products, and offers advice on labeling issues such as the floral source of honey, blends of honey and other sweeteners, and blends of honey and other ingredients.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More